Do you want to read an article? Please log in or register.
Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis
Related content
RECOMMENDED
Further Publications NeurologyFurther Publications Psychiatry
Daratumumab treatment for therapy-refractory anti-CASPR2 encephalitis
★ 1
Recommended by
Prof. Dr Christian Kamm, Faculty Member
J Neurol.
Scheibe F, Ostendorf L, Reincke SM, Prüss H, von Brünneck AC, Köhnlein M, Alexander T, Meisel C, Meisel A
doi: 10.1007/s00415-019-09585-6.
Further Publications NeurologyFurther Publications Psychiatry
An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models
Lancet Neurol.
Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F, Leypoldt F, Geis C, Lancaster E, Titulaer MJ, Rosenfeld MR, Graus F
doi: 10.1016/S1474-4422(19)30244-3.
Anxiety and Depression
Psychological therapies for treatment-resistant depression in adults
Cochrane Database Syst Rev.
Ijaz S, Davies P, Williams CJ, Kessler D, Lewis G, Wiles N
doi: 10.1002/
SPECIAL REPORT
Multiple Sclerosis
Vaccination Readiness in Multiple Sclerosis
RECOMMENDED
Migraine and Headache
Dual Therapy With Anti-CGRP Monoclonal Antibodies and Botulinum Toxin for Migraine Prevention: Is There a Rationale?
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Headache.
Pellesi L, Do TP, Ashina H, Ashina M, Burstein R
doi: 10.1111/head.13843.
Anxiety and Depression
Fluoroethylnormemantine, a Novel NMDA Receptor Antagonist, for the Prevention and Treatment of Stress-Induced Maladaptive Behavior
Biol Psychiatry
Chen BK, Luna VM, Shannon ME, Hunsberger HC, Mastrodonato A, Stackmann M, McGowan JC, Rubinstenn G, Denny CA
doi: 10.1016/j.biopsych.2021.04.024
Aging and Cognitive FunctionsAnxiety and Depression
Clinical outcomes and cost-effectiveness of brief guided parent-delivered cognitive behavioural therapy and solution-focused brief therapy for treatment of childhood anxiety disorders: a randomised controlled trial
Lancet Psychiatry
Creswell C, Violato M, Fairbanks H, White E, Parkinson M, Abitabile G, Leidi A, Cooper PJ
doi: 10.1016/
Migraine and HeadacheMultiple Sclerosis
Safety and efficacy of dual-lead thalamic deep brain stimulation for patients with treatment-refractory multiple sclerosis tremor: a single-centre, randomised, single-blind, pilot trial
Lancet Neurol.
Oliveria SF, Rodriguez RL, Bowers D, Kantor D, Hilliard JD, Monari EH, Scott BM, Okun MS, Foote KD
doi: 10.1016/
Psychosis and Schizophrenia
Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients
Nat Commun.
Jézéquel J, Johansson EM Dupuis JP, Rogemond V, Gréa H, Kellermayer B, Hamdani N, Le Guen E, Rabu C, Lepleux M Spatola M, Mathias E, Bouchet D, Ramsey AJ, Yolken RH, Tamouza R, Dalmau J, Honnorat J, Leboyer M, Groc L
doi: 10.1038/